152 related articles for article (PubMed ID: 32527650)
1. PML Nuclear Body Biogenesis, Carcinogenesis, and Targeted Therapy.
Li Y; Ma X; Wu W; Chen Z; Meng G
Trends Cancer; 2020 Oct; 6(10):889-906. PubMed ID: 32527650
[TBL] [Abstract][Full Text] [Related]
2. B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis.
Li Y; Ma X; Chen Z; Wu H; Wang P; Wu W; Cheng N; Zeng L; Zhang H; Cai X; Chen SJ; Chen Z; Meng G
Nat Commun; 2019 Aug; 10(1):3789. PubMed ID: 31439836
[TBL] [Abstract][Full Text] [Related]
3. The functional roles of PML nuclear bodies in genome maintenance.
Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
[TBL] [Abstract][Full Text] [Related]
4. PML nuclear body biogenesis and oligomerization-driven leukemogenesis.
Li Y; Ma X; Meng G
Blood Sci; 2020 Jan; 2(1):7-10. PubMed ID: 35399865
[TBL] [Abstract][Full Text] [Related]
5. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.
Guion L; Bienkowska-Haba M; DiGiuseppe S; Florin L; Sapp M
PLoS Pathog; 2019 Feb; 15(2):e1007590. PubMed ID: 30802273
[TBL] [Abstract][Full Text] [Related]
6. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
[TBL] [Abstract][Full Text] [Related]
7. PML tumour suppression and beyond: therapeutic implications.
Gamell C; Jan Paul P; Haupt Y; Haupt S
FEBS Lett; 2014 Aug; 588(16):2653-62. PubMed ID: 24548562
[TBL] [Abstract][Full Text] [Related]
8. PML Bodies in Mitosis.
Lång A; Lång E; Bøe SO
Cells; 2019 Aug; 8(8):. PubMed ID: 31416160
[TBL] [Abstract][Full Text] [Related]
9. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.
Cohen C; Corpet A; Roubille S; Maroui MA; Poccardi N; Rousseau A; Kleijwegt C; Binda O; Texier P; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2018 Sep; 14(9):e1007313. PubMed ID: 30235352
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
[TBL] [Abstract][Full Text] [Related]
12. Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.
Bienkowska-Haba M; Luszczek W; Keiffer TR; Guion LGM; DiGiuseppe S; Scott RS; Sapp M
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27860076
[TBL] [Abstract][Full Text] [Related]
13. An Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies.
Komatsu T; Nagata K; Wodrich H
J Virol; 2016 Feb; 90(3):1657-67. PubMed ID: 26608315
[TBL] [Abstract][Full Text] [Related]
14. RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G
Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493
[TBL] [Abstract][Full Text] [Related]
15. Phase separation is required for PML nuclear body biogenesis and function.
Wu W; Tan Y; Yin H; Jiang M; Jiang Y; Ma X; Yin T; Li Y; Zhang H; Cai X; Meng G
FASEB J; 2023 Jun; 37(6):e22986. PubMed ID: 37219517
[TBL] [Abstract][Full Text] [Related]
16. PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4.
Salsman J; Stathakis A; Parker E; Chung D; Anthes LE; Koskowich KL; Lahsaee S; Gaston D; Kukurba KR; Smith KS; Chute IC; Léger D; Frost LD; Montgomery SB; Lewis SM; Eskiw C; Dellaire G
Sci Rep; 2017 Mar; 7():45038. PubMed ID: 28332630
[TBL] [Abstract][Full Text] [Related]
17. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
[TBL] [Abstract][Full Text] [Related]
18. The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.
Guion LG; Sapp M
Front Cell Infect Microbiol; 2020; 10():35. PubMed ID: 32154186
[TBL] [Abstract][Full Text] [Related]
19. The Human CMV IE1 Protein: An Offender of PML Nuclear Bodies.
Scherer M; Schilling EM; Stamminger T
Adv Anat Embryol Cell Biol; 2017; 223():77-94. PubMed ID: 28528440
[TBL] [Abstract][Full Text] [Related]
20. Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells.
Hirano S; Udagawa O; Kobayashi Y; Kato A
Toxicol Appl Pharmacol; 2018 Dec; 360():150-159. PubMed ID: 30292834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
